Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trametinib for NF1-related Plexiform Neurofibroma
NCT03741101Phase 2Active, not recruiting
- Sponsor
- Region Skåne
- Start
- Jun 2019
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trametinib in plexiform neurofibroma (PN), sponsored by Region Skåne. Started Jun 2019; status: active, not recruiting.
02
Drugs
trametinib
03
Conditions
plexiform neurofibroma (PN)
Beyond the preview
Go deeper on NCT03741101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03741101.